Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
M. Mirdamadi (Tehran, Islamic Republic of Iran), M. Fathollahi (Tehran, Islamic Republic of Iran), A. Araghi (Augusta, United States of America). Do beta-blockers reduce sympathetic activity in patients with mild sleep breathing disorder without CPAP therapy?. 2150

Member's Comments

No comment yet.

Related content which might interest you: Compliance of positive airway pressure therapy in patients with sleep related breathing disorder Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients Source: Eur Respir J 2004; 23: 255-262 Year: 2004 The reversibility of hypoxemia in OSA patients is related to CPAP therapy Source: Eur Respir J 2005; 26: Suppl. 49, 112s Year: 2005 Eficacy of the treatment with CPAP in patients with chronic heart failure and sleep apnoea Source: Eur Respir J 2004; 24: Suppl. 48, 564s Year: 2004 Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment Source: Eur Respir J 2011; 39: 227-228 Year: 2012 Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment Source: Eur Respir J 2011; 39: 226-227 Year: 2012 Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment Source: Eur Respir J 2012; 39: 226-227 Year: 2012 Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment Source: Eur Respir J 2012; 39: 227-228 Year: 2012 Impact of CPAP treatment on sympathetic activity and renin-angiotensin-aldosterone system in normotensive men with obstructive sleep apnoea Source: Eur Respir J 2006; 28: Suppl. 50, 294s Year: 2006 Does CPAP therapy affect motor cortical excitability in patients with obstructive sleep apnea syndrome (OSAS)? Source: Annual Congress 2004 - CPAP therapy for OSA Year: 2004 The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Impact of bi-Level ventilation on sleep disordered breathing in patients using chronic opioids Source: Annual Congress 2010 - Complex sleep apnoea, opioids, adaptive servoventilation, bilateral positive airway pressure and continuous positive airway pressure Year: 2010 Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 Possibility of treating patients with obstructive sleep apnea syndrome and nocturnal asystoles using CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 Long term effects of CPAP therapy in sleep apnea patients with metabolic syndrome Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010 Effects of CPAP treatment on anxiety and depression in patients with OSAS Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017 Clinical implications of residual sleep apnoea after chronic CPAP therapy Source: Breathe 2011; 7: 289-290 Year: 2011 Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients? Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Duration of CPAP use in the 1st night of treatment predicts success of therapy in patients with the sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 100s Year: 2002 Telecoaching to improve physical activity in patients with obstructive sleep apnea treated with CPAP Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020